Clinical Efficacy of Biomimetic Hydroxyapatite in the Treatment of Molar Incisor Hypomineralization.
Effects of Biomimetic Hydroxyapatite in the Treatment of Molar Incisor Hypomineralization: a Randomized Clinical Trial.
1 other identifier
interventional
25
1 country
1
Brief Summary
The aim of the following study is to evaluate che clinical efficacy of a toothpaste with biomimetic hydroxyapatite for the management of Molar-Incisor Hypomineralization. Patients who agree to participate to the study will use Biorepair toothpaste for the first 7 days of the month for 3, 6 and 9 months. The following indices will be measured: BEWE, Bleeding Index, Gingival index, Plaque index and the dental sensitivity test. The contralateral tooth will be used as control if not affected by MIH; otherwise, adjacent teeth will be considered.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 16, 2021
CompletedFirst Posted
Study publicly available on registry
March 22, 2021
CompletedStudy Start
First participant enrolled
March 25, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2022
CompletedApril 4, 2022
March 1, 2022
10 months
March 16, 2021
March 22, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Change of BI - Bleeding Index
Scoring criteria: * 0: absence of bleeding after 30 seconds * 1: bleeding observed after 30 seconds * 2: immediate bleeding
Study begin, 1,2,3, 6 and 9 months
Change of GI - Gingival Index (Loe and Silness, 1963)
Scoring criteria: * 0 = normal gingiva. * 1 = mild inflammation, edema and swelling; no bleeding. * 2 = moderate inflammation with edema, swelling and bleeding on probing. * 3 = severe inflammation with marked edema, redness tissues, ulceration and spontaneous bleeding.
Study begin, 1,2,3, 6 and 9 months
Change of PCR - Plaque Control Record (O'Leary, 1972)
4 surfaces scored (mesial, distal, vestibular, labial/palatal) per tooth by means of plaque relevator. The Index is calculated multiplying the total number of surfaces with plaque per 100.
Study begin, 1,2,3, 6 and 9 months
Change in Schiff Air Index - Dental sensitivity test
Scoring criteria: 0\. the subject did not respond to air blasting; 1. the subject responded to air blasting; 2. the subject responded to air blasting and requested discontinuation; 3. the subject responded to air blasting, requested discontinuation and considered the stimulus to be painful.
Study begin, 1,2,3, 6 and 9 months
Change of BEWE Index - Basic Erosive Wear Examination (Barlet et al., 2008)
Scoring criteria: * 0: no erosive tooth wear; * 1: initial loss of surface texture; * 2: distinct defect, hard tissue loss \< 50% of the surface area; * 3: hard tissue loss ≥ 50% of the surface area. Additionally, risk level for clinical management will be assessed.
Study begin, 1,2,3, 6 and 9 months
Study Arms (2)
Trial Group
EXPERIMENTALTeeth from this group suffer from MIH. They will be evaluated after home oral care with BioRepair toothpaste containing microRepair®.
Control Group
ACTIVE COMPARATORTeeth from this group suffer from MIH. They are in the contralateral quadrants in respect to teeth from trial group. They will not be treated with the hydroxyapatite toothpaste.
Interventions
Teeth from this group will undergo the application of Biorepair Toothpaste for the first 7 days of the month for 9 months (1 application per day that lasts 10 minutes).
Teeth from this group will not be treated with the experimental toothpaste.
Eligibility Criteria
You may qualify if:
- presence of at least 2 enamel demineralizations of permanent molars and incisors (Molar-Incisor Hypomineralization - MIH) in contralateral quadrants
- good general health (absence of systemic diseases)
You may not qualify if:
- patients undergoing orthodontic therapy
- patients taking drugs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Unit of Dental Hygiene - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Paediatrics - University of Pavia
Pavia, Lombardy, 27100, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrea Scribante, DDS, PhD.
University of Pavia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Resident, Principal Investigator
Study Record Dates
First Submitted
March 16, 2021
First Posted
March 22, 2021
Study Start
March 25, 2021
Primary Completion
January 30, 2022
Study Completion
February 1, 2022
Last Updated
April 4, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share
Data will be available upon motivated request to Principal Investigator